Definitive Contract HHSD200201354010C

Award Date 2/22/13
Potential Completion Date 2/21/14
Potential Value $6.4M
Federal Agency
CDC Pittsburgh
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
West Point, PA 19486, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to the American Pharmacists Association (APhA) for $450,000.00. The contract is for "ADULT VACCINES AND PHARMACIES" and has a firm fixed price pricing type with a completion date of September 26, 2025. APhA is a not-for-profit organization that advocates for the pharmacy profession and has received prior federal contract and grant awards from agencies such as...
This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned for-profit organization, to provide a variety of adult vaccines to the Department of Health and Human Services Centers for Disease Control and Prevention. The contract is a definitive contract with a firm fixed price, valued at $36,284,020.90, and does not have a set-aside designation. The period of performance is from July 1, 2017, to June 30, 2018, with the place of performance being Sanofi Pasteur's facility in...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer, to provide FLUZONE TRIVALENT HIGH DOSE 65 YEARS AND OLDER vaccines. The contract has a potential value of $90,768.60 and a completion date of October 31, 2024. It is not set aside for any specific business category. Sanofi Pasteur Inc. has a track record of providing a range of vaccines and pharmaceuticals to...
This is a $37,190,000.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. The contract, which ran from July 1, 2016 to June 30, 2017, was for the 2016 Vaccine for Adults (VFA) program and did not have a set-aside designation. Pfizer, a global pharmaceutical corporation, served as the prime contractor and supplied a variety of pharmaceutical products and vaccines to support the CDC's healthcare initiatives. This included...
This is a firm fixed price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Sanofi Pasteur Inc. to provide high single dose trivalent influenza vaccine. The contract has a ceiling value of $193,016.00 and a period of performance ending on October 31, 2015. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer that has received numerous vaccine and pharmaceutical contracts from federal agencies, including the VA, Indian Health Service, CDC, DLA, HHS,...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Merck Sharp & Dohme Corp. for the "MERCK PEDIATRIC VACCINE CONTRACT". The contract has a firm fixed price pricing type and a ceiling value of $39,055,333,994.98. The period of performance is from April 1, 2010 to March 31, 2011, and the place of performance is West Point, Pennsylvania. This contract was not set aside for any specific business category. The...
<p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded Sanofi Pasteur Inc. a $638,637.60 firm fixed price delivery order contract to provide FLUZONE influenza vaccines. The contract has a period of performance starting on March 13, 2023 through October 15, 2023, with all work to be conducted in San Diego, California.</p>
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of pharmaceutical goods. The $28.3 billion firm fixed price contract is for the provision of pediatric vaccines under the Vaccines for Children (VFC) program. The contract has no set-aside designation and runs through March 31, 2010. Sanofi Pasteur operates a facility in Swiftwater, Pennsylvania to fulfill the...
The Department of Veterans Affairs Veterans Health Administration awarded a $108,182 delivery order contract to Sanofi Pasteur Inc. for influenza vaccines. As the prime contractor, Sanofi Pasteur will provide FLUZONE vaccines in support of VHA's Veterans Integrated Service Network 21 located in Palo Alto, California. The firm fixed price contract runs from April 14, 2020 to September 30, 2020 and was awarded without a set aside designation. The delivery order was issued against an existing...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the VAXELIS vaccine in 0.5 mL vials, with a ceiling value of $3,574.04 and a completion date of July 3, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...

ADULT VACCINE CONTRACT

Posted 2/22/13, 12:00 AM